Showing results (101-110 of 504) with videos related to
Sort By:
Pageof 51
Current Opinion in Clinical Nutrition and Metabolic Care|November 27, 2025
Core outcome sets and trials of nutrition and metabolism interventionsAnnika Reintam Blaser, Thomas Davies, Kaspar F BachmannImmunological Reviews|May 31, 2020
The 3Ds in virus-like particle based-vaccines: "Design, Delivery and Dynamics"Mona O Mohsen, Gilles Augusto, Martin F BachmannDrug Discovery Today|October 24, 2006
A second vaccine revolution for the new epidemics of the 21st centuryMark R Dyer, Wolfgang A Renner, Martin F BachmannInternational Archives of Allergy and Immunology|June 17, 2020
Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and InfectionHans-Uwe Simon, Alexander V Karaulov, Martin F BachmannEuropean Radiology|April 7, 2004
MR imaging of compartment syndrome of the lower leg: a case control studyM B Rominger, C J Lukosch, G F BachmannMolecular Immunology|May 14, 2004
Enhanced apoptotic activity of a structurally optimized form of galectin-1Patrick Bättig, Philippe Saudan, Tea Gunde, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activityAndrea Jegerlehner, Nicole Schmitz, Tazio Storni, et al.Biotechniques|August 25, 2005
Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteinsLidia Ivanova, Johanna Brändli, Philippe Saudan, et al.Current Opinion in Immunology|July 20, 2025
The impact of viral evolution on vaccine development for SARS-CoV-2Martin F Bachmann, Mona O Mohsen, Daniel E SpeiserBritish Journal of Haematology|September 1, 1985
Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PAM Stalder, J Hauert, E K Kruithof, et al.Pageof 51